Overview:
Home infusion therapy refers to administration of biological and drugs in patient’s home, wither by patient themselves, family, nurse and others. Home infusion services include patient training and education, administration, care coordination, pharmacy services and others. These services and supplies are usually provided by physicians and pharmacy staff, where initially, the patient picks up medications form physician’s office. Nursing services for home care are also provided through agencies.
Geriatric population is the largest consumer of home infusion therapy. As the global population is ageing, this population possesses a high risk and susceptibility of this population group to develop chronic conditions that require infusion therapy. Growing demand for home healthcare by disabled patient group will additionally widen the base for home infusion therapy. Augmenting use of home infusion therapy also results in reduction in hospital readmission and in-patient stay, thus containing healthcare costs. Home infusion therapy is also instrumental in reducing the risk of contracting nosocomial infection thus presenting potential market penetration opportunity.
The global home infusion therapy market is segmented on the following bases:
1. Product Type
a. Infusion Pumps
b. IV Sets
c. IV Cannulas
2. Therapy Type
a. Ant-infectives
b. Chemotherapy
c. Hydration Therapy
d. Specialty Pharmaceuticals
e. Clinical Nutrition
f. Consumables Others
3. Geography
a. North America
i. US
ii. Canada
b. Europe
i. UK
ii. Germany
iii. Rest of Europe
c. Asia-Pacific
i. Japan
ii. China
iii. Rest of APAC
d. Latin America
e. Middle East and Africa
Key players identified for healthcare analytical testing market include but are not limited to:
Fresenius Kabi, Baxter, Inc. B. Braun Melsungen AG, Smiths Medical, CareFusion Corporation, Caesarea Medical Electronics and several others
This report offers:
